Bilbao-Garay Pérdida de Peso
Bilbao-Garay Pérdida de Peso
Bilbao-Garay Pérdida de Peso
Original article
Received 13 August 2001; received in revised form 17 January 2002; accepted 21 January 2002
Abstract
Background: Involuntary weight loss (IWL) is a frequent complaint with a difficult diagnosis. Any one of a number of different
diseases may be the source of the symptom. However, there is no universal clinical protocol that can help physicians study this complex
syndrome. Methods: In March 1998, we defined a diagnostic protocol for the study of IWL. IWL was defined as an involuntary and
documented weight loss of at least 5% of the usual body weight in the previous 3 months. We analyzed 78 consecutive patients with IWL
who came to our clinic between March 1998 and December 2000. Results: An organic disease was found in 56% of cases; cancer,
metabolic and digestive diseases were the most common entities. Psychiatric problems were found in 33% of cases. After extensive study,
an idiopathic group of 11% was identified. The variables that were independently predictive of a final diagnosis of organic disease were:
age.50 years (OR: 8.6, CI 95%: 1.7–43.6), psychiatric symptoms (OR: 0.2, CI 95%: 0.1–0.8), smoking (OR: 14.3, CI 95% 2.3–74), the
presence of guide symptoms (OR: 8.0, CI 95%: 1.8–34.4), and anemia (OR: 3.1, CI 95%: 2.5–387). Sixteen percent of the patients died,
more often those suffering from organic diseases. Based on multivariate regression coefficients, a clinical risk score was established.
Conclusions: IWL is a complex and frequent syndrome with a 16% rate of mortality during the first year. A protocol based on clinical
data can help in the management of IWL. Our clinical prediction rule may help physicians to identify those patients with IWL who are
likely to have an underlying organic disease. 2002 Elsevier Science B.V. All rights reserved.
Keywords: Weight loss; Clinical protocol; Clinical prediction rule; Diagnosis; Prognosis
0953-6205 / 02 / $ – see front matter 2002 Elsevier Science B.V. All rights reserved.
PII: S0953-6205( 02 )00032-8
J. Bilbao-Garay et al. / European Journal of Internal Medicine 13 (2002) 240 – 245 241
Table 1
Protocol for the study of patients with involuntary weight loss
1. Complete medical history: previous diseases, psychiatric problems, and
surgical procedures. Social problems (isolation, poverty, unavailability of
preferred foods, inadequate education) especially in the elderly. Drug history,
toxic habits, cigarette smoking, alcohol and illicit drugs
2.2. Study protocol illness in the previous month that could explain the weight
loss.
In March 1998 we defined a diagnostic protocol for the We considered a causal relationship between the weight
study of involuntary weight loss (IWL) adapted from loss and a given disease when a neoplasm was found or
Foster [7] (Tables 1 and 2). From March 1998 to De- when changes in weight loss paralleled changes in disease
cember 2000, all patients referred to our clinic with IWL status, as previous authors have done [3].
as the main clinical complaint were included in the study. Thirteen of the 91 patients were lost after the first visit
IWL was defined as an involuntary and documented and were not included in the analysis. We were thus left
weight loss of at least 5% of the usual body weight in the with 78 patients to analyze in whom a clinical diagnosis
previous 3 months or more than 10% during the previous 6 was reached or who were followed for at least 6 months.
months, as reported in other studies [1–6]. From their clinical charts we were able to obtain and
record demographic information (age, sex), toxic habits
2.3. Patients (smoking, alcohol consumption in g / day, use of illicit
drugs), previous diseases (hypertension, diabetes, other
Between March 1998 and December 2000, 91 of 2968 medical diseases, and previous psychiatric disorders),
patients over 15 years of age met the above-mentioned duration of the weight loss (number of days from the
criteria for IWL (3%). Patients were excluded from the beginning of the IWL to the first visit in the office),
study if: (1) they had voluntary weight loss or (2) if they accompanying symptoms, abnormal physical findings on
had been diagnosed as having a medical or psychiatric physical examination, degree of weight loss, complemen-
Table 2
Basic laboratory data for patients with involuntary weight loss
Complete blood cell count
Erythrocyte sedimentation rate
Urinalysis
Multiphase chemical screen: glucose, creatinine, SGOT, SGPT, alkaline
phosphatase, bilirubin, albumin, calcium, electrolytes, cholesterol, triglycerides
Ultrasensitive thyrotropin assay
Chest film
HIV testing if risk factors are present
Fecal occult blood testing at 40 years or older
242 J. Bilbao-Garay et al. / European Journal of Internal Medicine 13 (2002) 240 – 245
tary data (blood cell count, blood chemistry, liver en- The most frequent symptoms seen were asthenia (64%),
zymes, thyrotropin assay, radiological studies, and other anorexia (62%), depressive symptoms (sadness, insomnia,
complementary data registered in the clinical record), final easy crying, loss of interest) (27%), abdominal pain
diagnosis, and the number of days of follow-up. (26%), nausea and vomiting (5%), arthralgia (3%), and
For the purpose of analysis, patients were divided into miscellaneous symptoms (3%). Patients were followed up
two groups: group 1, which included patients with organic for 376.36244 days (range: 9–982 days).
disease (neoplasia or other medical diseases), and group 2, A diagnosis that could explain the IWL was reached in
patients with no organic disease (psychiatric illness and 69 (88%) patients (Table 3). Eighteen patients (23%) were
patients with unknown diagnosis). The idiopathic group, diagnosed as having neoplasia, 25 patients (32%) had
hereafter referred to as weight loss of unknown origin other medical conditions, and 26 patients (33%) had
(WLUO), was diagnosed after an extensive negative psychiatric disorders; in nine patients (11%) we did not
clinical study and a minimum follow-up of 3 months. find any disease to explain the IWL (WLUO). One patient
Patients finally diagnosed as having psychiatric disease did initially diagnosed as having WLUO was finally diagnosed
not have any other known diagnosis that justified IWL, nor with cancer at 6 months of follow-up.
had they had any acknowledged psychiatric illness in the Clinical symptoms and laboratory data are shown in
previous month that could have been linked to IWL. Table 4. The variables most frequently associated with
organic disease (group 1) were: male sex, age over 50
2.4. Statistics years, alcohol consumption.40 g / day, smoking, abnor-
malities in basic laboratory data, and the need for hospital
Patients were divided into two groups according to the admission (P,0.05). Depressive symptoms (sadness, easy
diagnosis of organic or non-organic disease. All demo- crying, insomnia, apathy) and previous psychiatric disease
graphic, clinical, and complementary data were compared were more frequent in patients in group 2 (no organic
between these groups. The two-tailed Student’s t-test for disease). Anorexia was presented more frequently in the
quantitative variables and the x 2 -test for dichotomous organic disease group, especially in cancer patients, al-
variables were used. Odds ratios and 95% confidence though this symptom did not reach a significant difference
intervals were estimated from the regression coefficients. (Table 4). Mean weight loss (9.265.1 kg; 1360.6% of
The most clinically relevant variables and those statisti- body weight) and the duration of symptoms (35% more
cally significant were analysed according to a multiple than 6 months; 39% less than 3 months) were similar in
logistic model to identify independent correlates of organic both groups. As a group, the patients with WLUO were
disease (a P-value,0.1 was used to include variables in very similar to the patients with a final diagnosis of
the model). A backward, stepwise procedure, with P.0.10 psychiatric disease, except for sex, with male patients
as the criterion for exclusion, was used to find the best clearly predominating in the WLUO subgroup (77 vs.
predictive models for organic disease. 11%, P,0.05), presence of psychiatric symptoms (11 vs.
We developed a clinical model to stratify the probability 50%, P,0.05), and previous psychiatric disease (11 vs.
of organic disease into high, moderate, and low categories. 61%, P,0.05). Age, physical examination, and laboratory
A simple, integral diagnostic score was computed from the data were similar in both subgroups.
multivariate logistic regression model, assigning points in Only 25 patients (34%) had a combination of clinical
proportion to the regression coefficients. The ideal score symptoms that helped in the diagnosis. These symptoms,
was defined as a score based on objective and reproducible defined as chief complaints pointing to disease of a specific
variables that were clinically relevant. organ (‘guide symptoms’), such as gastrointestinal or
All statistical analyses were done with the Statistical pulmonary symptoms, were present more frequently in
Package for the Social Sciences (SPSS, version 8.0) [8]. patients with organic disease (50 vs. 14%, P,0.001).
Patients in group 1 (organic disease) had lower hemo-
globin and cholesterol levels than patients with no organic
3. Results disease (group 2). In addition, globular sedimentation rate
(GSR) and liver enzymes were higher in patients with
Of the 91 patients with IWL seen at our internal organic disease (Table 4).
medicine clinic, 78 (86%) were included in the study. The Twelve patients (16%) died during the follow-up period,
13 patients who were not included because they did not and mortality was higher in group 1 than in group 2 (23 vs.
have enough follow-up to achieve a diagnosis did not 4%, P,0.001). Patients diagnosed as having WLUO did
differ in sex or age from the patients who were included. not deteriorate during the follow-up period, except for one
Fifty-one percent of the patients were women, and their patient who was eventually diagnosed as having dissemi-
mean age was 59619 years. nated cervical cancer at 6 months after the first visit and
The primary care physician referred 85% of the patients. who died 2 months later.
Eighteen patients (23%) were hospitalized for study due to The following variables were included in a logistic
a deterioration in their clinical conditions. regression model: age, sex, tobacco use, depressive symp-
J. Bilbao-Garay et al. / European Journal of Internal Medicine 13 (2002) 240 – 245 243
Table 3
Diseases found in 78 patients with involuntary weight loss
Medical diseases: 25 (32%) Cancer 18 a : (23%) Psychiatric diseases: 26 (33%)
Digestive diseases: 5 (6%) Lymphoma 5 Depression 17 (22%)
Inflammatory bowel disease 2 Renal cancer 2 Anxiety 7 (9%)
Gastritis 1 Gastric cancer 2 Anorexia nervosa 2 (3%)
Chronic hepatitis 1 Colon carcinoma 2
Malabsorption 1 Uterine cancer 2 a
Metabolic diseases: 8 (10%) Lung cancer 1
Hyperthyroidism 3 Pancreas cancer 1
Diabetes mellitus 2 Prostate cancer 1
Alcohol abuse 3 Liposarcoma 1
Infections: 4 (5%) Laryngeal cancer 1
Urinary infection 1
Lung abscess 1
Lung tuberculosis 1
HIV infection 1
Miscellaneous: 7 (9%)
Giant cell arteritis 2
Systemic lupus erythematosus 1
Emphysema 1
Cerebrovascular disease 1
Non-specific lymphadenopathy 1
Amyotrophic lateral sclerosis 1
a
One patient originally classified as having weight loss of unknown origin was diagnosed 6 months later with uterine cancer.
toms, previous disease, the presence of guide symptoms, Based on multivariate regression coefficients, a clinical
normal physical examination, and abnormalities in labora- risk score ranging from 24 to 7 points was established.
tory data. The variables that were independently predictive The best cut-off score for identifying a high probability
of a final diagnosis of organic disease were: the presence group was 3 points. Patients with a total score of 1–3
of guide symptoms (OR: 8.0, CI 95%: 1.8–34.4); anemia points have a moderate probability and patients with less
(OR: 3.1, CI 95%: 2.5–387); age.50 years (OR: 8.6, CI than 1 point have a low risk of organic disease (Table 5).
95%: 1.7–43.6); psychiatric symptoms (OR: 0.2, CI 95%: The sensitivity of the formula is 94% with a specificity of
0.1–0.8), and smoking (OR: 14.3, CI 95% 2.3–74). 68%.
Table 4
Clinical and laboratory variables in 78 patients with involuntary weight loss
Group 1 Group 2 P-value
N543 N535
Age (years6S.D.) 67616 50619 ,0.001
Previous psychiatric disease (%) 9 48 ,0.001
Male sex (%) 68 28 0.001
Smokers (%) 52 23 0.008
Alcohol (ingestion more than 40 g / day) (%) 25 6 0.02
Presence of guide symptoms (%) 50 14 0.001
% kg lost 8.964 9.566 0.601
Abdominal pain (%) 20 34 0.167
Sadness, anxiety, and other psychiatric 16 40 0.01
symptoms (%)
Normal physical examination (%) 41 97 ,0.001
Anorexia (%) 68 54 0.206
Asthenia (%) 68 60 0.450
Hemoglobin (mean6S.D., g / dl) 1262.5 1461.2 0.001
Alkaline phosphatase (mean6S.D., U / l) 2506158 145646 ,0.001
SGOT (mean6S.D., U / l) 32629 1765 0.005
SGPT (mean6S.D., U / l) 45681 1668 0.03
Cholesterol (mean6S.D., mg / dl) 174643 209640 0.001
Erythrocyte sedimentation rate, 45639 1463 ,0.0001
(mean6S.D., mm / h)
Need for hospital admission (%) 36 6 ,0.001
Mortality (%) 23 4 ,0.001
244 J. Bilbao-Garay et al. / European Journal of Internal Medicine 13 (2002) 240 – 245
admission. Thompson and Morris [4] limited their study to we recommend a follow-up of at least 6 months in patients
elderly patients, and thus their results cannot be extrapo- with no apparent diagnosis (WLUO) in order to rule out an
lated to younger patients. This age group can have other organic disease.
etiologies of involuntary weight loss, the most common
conditions appearing to be related to dementia, depression,
drug reactions, oral problems and chronic diseases [13,14]. Acknowledgements
Leduc et al. [5] found a high proportion of psychiatric and
idiopathic patients in their study; organic diseases were We thank Alejandra Perez del Real for her helpful
found in no more than 29% of their IWL patients. In their technical assistance.
study, they only included patients with a negative basic
study, thus representing a group similar to the one we have
defined as WLUO. Not surprisingly, as with our own
group, their WLUO group had a low prevalence of serious References
organic disorders. Therefore, their results cannot be ex-
[1] Reife CM. Involuntary weight loss. Med Clin North Am
trapolated to the whole range of patients with IWL seen in
1995;79:299–313.
a general internal medicine clinic. Huerta and Viniegra [6] [2] Marton KI, Sox Jr. HC, Krupp JR. Involuntary weight loss:
limited their study to patients who lost weight in less than diagnostic and prognostic significance. Ann Intern Med
6 months. Thirty-five percent of our patients would have 1981;95:568–74.
been excluded if we had applied this criterion. From our [3] Rabinovitz M, Pitlik SD, Leifer M et al. Unintentional weight loss: a
retrospective analysis of 154 cases. Arch Intern Med 1986;146:186–
experience, as well as that of Rabinovitz et al. [3], we are
7.
inclined to say that patients who lose weight within 6 [4] Thompson MP, Morris LK. Unexplained weight loss in the ambulat-
months do not differ from patients who lose weight more ory elderly. J Am Geriatr Soc 1991;39:497–500.
slowly. However, additional studies are needed to confirm [5] Leduc D, Rouge PE, Rousset H et al. Clinical study of 105 cases of
this. Quick weight loss could suggest an organic disease as isolated weight loss in internal medicine. Rev Med Interne
1988;9:480–6.
the cause, but our data do not support this hypothesis.
[6] Huerta G, Viniegra L. Involuntary weight loss as a clinical problem.
Limitations of our study could be related to the number Rev Invest Clin 1989;41:5–9.
of patients seen. It is possible that if we had had a larger [7] Foster DW. Gain and loss in weight. In: Harrison’s principles of
sample of IWL patients, other diseases might have ap- internal medicine, 14th ed., McGraw-Hill, 1998, pp. 244–6.
peared. However, our results are in accordance with other [8] Statistical Package for Social Sciences (computer program). Win-
dows version, release 8.0. SPSS, Chicago, 1998.
studies [2–6], especially with regard to the idiopathic
[9] Wise GR, Craig DC. Evaluation of involuntary weight loss. Where
group. Our sample represents a group of patients seen by a do you start? Post Medicine 1994;95:143–50.
general internist, and this sample may differ from those [10] Wallace JI, Schwartz RS, LaCroix AZ, Uhlmann RF, Pearlman RA.
seen by general practitioners. Our patients may be sicker Involuntary weight loss: incidence and clinical significance. J Am
than those seen by general practitioners, but we think that Geriatr Soc 1995;43:329–37.
[11] Yaari S, Goldbourt U. Voluntary and involuntary weight loss:
the protocol we propose can also be useful for them.
associations with long term mortality in 9228 middle aged and
IWL is a complex syndrome with 16% mortality in the elderly men. Am J Epidemiol 1998;148:546–55.
first year in our experience, a figure similar to that found in [12] McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiel IG, Richardson
other studies [2]. Since this is a frequent syndrome that WS. User guides to the medical literature. How to use articles about
consumes considerable diagnostic resources (8% of the clinical decision rules. J Am Med Assoc 2000;284:79–84.
patients consult a general internist for IWL [1,9]), IWL [13] Sullivan DH, Martin W, Flaxman N, Hagen JE. Oral health problems
and involuntary weight loss in a population of frail elderly. J Am
must receive more attention. We think that a protocol based Geriatr Soc 1993;41:725–31.
on clinical data can help in the management of IWL, and [14] Palmer R. Failure to thrive in elderly: diagnosis and management.
we present a prediction rule here for that purpose. Finally, Geriatrics 1990;45:47–55.